This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...